| Mahlon Arthur Bradley, MD | |
|
7 Page Hill Rd, Berlin, NH 03570-3531 | |
| (603) 752-2300 | |
| (603) 752-1836 |
| Full Name | Mahlon Arthur Bradley |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 39 Years |
| Location | 7 Page Hill Rd, Berlin, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801889761 | NPI | - | NPPES |
| J06476 | Other | MA | BLUE CROSS BLUE SHIELD |
| 0028303 | Other | NEIGHBORHOOD HEALTH PLAN | |
| 0901140 | Other | UNITED HEALTHCARE | |
| 1021940 | Medicaid | VT | |
| 39355 | Other | FALLON COMMUNITY HEALTH | |
| 52663 | Other | CIGNA | |
| P00018882 | Other | RAILROAD MEDICARE | |
| 057227 | Other | TUFTS HEALTH PLAN | |
| 171031 | Other | HARVARD PILGRIM | |
| 2997952 | Other | AETNA | |
| 3025101 | Medicaid | MA | |
| 522367186 | Other | UNICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Androscoggin Valley Hospital | Berlin, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Androscoggin Valley Hospital Inc | 2365350725 | 43 |
News Archive
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish nine new Research Units. This decision was taken by the DFG's Senate at its February session in Bonn. The new groups are intended to provide researchers with the opportunity to address current and urgent issues in their fields and to develop new research strategies.
In a consensus report released Wednesday, Oct. 23, the National Academy of Medicine makes recommendations for system-level change needed to improve the professional well-being of clinicians, students and trainees across health care.
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.
› Verified 4 days ago
| Entity Name | Androscoggin Valley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386680593 PECOS PAC ID: 2365350725 Enrollment ID: O20040402000121 |
News Archive
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish nine new Research Units. This decision was taken by the DFG's Senate at its February session in Bonn. The new groups are intended to provide researchers with the opportunity to address current and urgent issues in their fields and to develop new research strategies.
In a consensus report released Wednesday, Oct. 23, the National Academy of Medicine makes recommendations for system-level change needed to improve the professional well-being of clinicians, students and trainees across health care.
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.
› Verified 4 days ago
| Entity Name | Androscoggin Valley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679526644 PECOS PAC ID: 2365350725 Enrollment ID: O20040929000254 |
News Archive
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish nine new Research Units. This decision was taken by the DFG's Senate at its February session in Bonn. The new groups are intended to provide researchers with the opportunity to address current and urgent issues in their fields and to develop new research strategies.
In a consensus report released Wednesday, Oct. 23, the National Academy of Medicine makes recommendations for system-level change needed to improve the professional well-being of clinicians, students and trainees across health care.
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mahlon Arthur Bradley, MD Po Box 547, Att: Cvmc-finance Dept, Barre, VT 05641-0547 Ph: (802) 225-3970 | Mahlon Arthur Bradley, MD 7 Page Hill Rd, Berlin, NH 03570-3531 Ph: (603) 752-2300 |
News Archive
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish nine new Research Units. This decision was taken by the DFG's Senate at its February session in Bonn. The new groups are intended to provide researchers with the opportunity to address current and urgent issues in their fields and to develop new research strategies.
In a consensus report released Wednesday, Oct. 23, the National Academy of Medicine makes recommendations for system-level change needed to improve the professional well-being of clinicians, students and trainees across health care.
Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.
The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians - today said physicians should consider lowering the dose of the steroid dexamethasone when treating patients with multiple myeloma.
› Verified 4 days ago
Delphine Glorieux-sullivan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-2300 Fax: 603-752-8231 |